ABIFINA

CONTATO
ASSOCIE-SE
LOGIN
  • Sobre
    • Quem somos
    • Código de Conduta Ética
    • Comitês
    • Estatuto Social
    • Estrutura organizacional
    • Galeria dos Presidentes
    • História
    • Segmentos da Química Fina
  • Prêmios
    • Prêmio Alcebíades de Mendonça Athayde
    • Prêmio Denis Barbosa
  • Associados
  • Notícias
    • ABIFINA na mídia
    • Associado em foco
    • Acontece na ABIFINA
    • Outras Notícias
  • Eventos
  • Produtos e serviços
    • ABIFINA Divulga
    • Clipping Diário de Notícias
    • Estatísticas
    • Centro de Monitoramento de Patentes
      • MPP Agro
      • MPP BIO
      • MPP Cannabis
      • MPP FDA
      • MPP FDA Biossimilares
      • MPP Saúde Animal
      • MPP SUS
    • Observatório de Ilegais
    • Panorama Regulatório Internacional
    • Propriedade Intelectual
      • Processo Administrativo de Nulidade (PAN)
      • Redação de Patentes
      • Relatórios de Patenteabilidade
      • Subsídios Técnicos
    • Resumo Semanal
  • Publicações
    • Revista FACTO
    • Todas as publicações
CONTATO

Notícias

08/08/2021

A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency

The SARS-CoV-2 receptor angiotensin converting enzyme 2 (ACE2) was previously engineered into a high affinity tetravalent format (ACE2-Fc-TD) that is...

Repositório Covid-19
ABIFNA presente na reunião do GIPI
05/08/2021

ABIFNA presente na reunião do GIPI

ABIFINA participa da reunião de alinhamento para definir a participação e a
colaboração das entidades da sociedade civil no...

Acontece na ABIFINA
04/08/2021

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

Thrombosis and inflammation may contribute to morbidity and mortality among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose...

Repositório Covid-19
04/08/2021

Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19

REGEN-COV (previously known as REGN-COV2), a combination of the monoclonal antibodies casirivimab and imdevimab, has been shown to markedly reduce...

Repositório Covid-19
03/08/2021

The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19

The coronavirus disease 2019 (COVID-19) pandemic has caused significant morbidity and mortality on a global scale. The etiologic agent, severe...

Repositório Covid-19
03/08/2021

Anti-SARS-CoV-2 and anti-cytokine storm neutralizing antibody therapies against COVID-19: Update, challenges, and perspectives

Coronavirus disease 2019 (COVID-19) has been declared by the World Health Organization (WHO) as a pandemic since March 2020. This...

Repositório Covid-19
02/08/2021

NSAIDs and COVID-19: A Systematic Review and Meta-analysis

Nonsteroidal anti-inflammatory drugs (NSAIDs) have been discouraged for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, fearing...

Repositório Covid-19
02/08/2021

S100A8 may govern hyper-inflammation in severe COVID-19

The coronavirus disease 2019 (COVID-19) pandemic threatens human species with mortality rate of roughly 2%. We can hardly predict the...

Repositório Covid-19
02/08/2021

SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies

COVID-19 pandemic has emerged as a result of infection by the deadly pathogenic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), causing...

Repositório Covid-19
02/08/2021

Elevated INR in a COVID-19 patient after concomitant administration of favipiravir and warfarin: A case report

Favipiravir is a promising treatment candidate for managing coronavirus disease 2019 (COVID-19). Warfarin has many drug interactions, but no interactions...

Repositório Covid-19
31/07/2021

Remdesivir for the treatment of COVID 19: review of the pharmacological properties, safety and clinical effectiveness

Remdesivir is a nucleoside analog that inhibits viral RNA replication by blocking RNA-dependent RNA polymerase. First developed and tested during...

Repositório Covid-19
30/07/2021

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2

In the battle against COVID-19, drugs discovered in repurposing screens are of particular interest because these could be rapidly implemented...

Repositório Covid-19
  • « anterior
  • 1
  • 2
  • 3
  • 4
  • …
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • …
  • 317
  • 318
  • 319
  • 320
  • próxima »
  • Sobre
  • Associados
  • Notícias
  • Eventos
  • Estatísticas
  • Publicações
  • Contato
  • Política de Privacidade
Av. Churchill, 129 • Sala 1201 • Centro • Rio de Janeiro • RJ
+55 21 3125-1400 [email protected]

Todos os direitos reservados © 2025 - ABIFINA

Desenvolvido por Conceito Comunicação Integrada
Login
Esqueci a senha